Immatics Biotechnologies GmbH

Germany


 
Total IP 1,146
Total IP Rank # 1,170
IP Activity Score 3.6/5.0    854
IP Activity Rank # 858
Stock Symbol
ISIN NL0015285941
Market Cap. 909.10004M  (EUR)
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

882 25
76 19
104 19
21
 
Last Patent 2025 - Antigen binding proteins specifi...
First Patent 2001 - Use of the heat shock protein gp96
Last Trademark 2025 - SUPRAME
First Trademark 2004 - IMMATICS

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Conducting of medical, scientific and clinical studies in the field of engineered T-cell receptor...
2024 Invention Antigen binding proteins specifically binding ct45. The present invention provides an antigen bi...
Invention Immunotherapy with a*01 restricted peptides and combination of peptides against cancers and relat...
Invention Novel peptides and combination of peptides for use in immunotherapy against small cell lung cance...
Invention Immunotherapy against several tumors including lung cancer. A method of treating a patient who h...
Invention Bma031 antigen binding polypeptides. Antigen binding polypeptide specifically binding to a α/β T...
Invention Peptides and t cells for use in immunotherapeutic treatment of various cancers. The present inve...
Invention Method for high throughput peptide-mhc affinity screening for tcr ligands. The present invention...
Invention Novel immunotherapy against several tumors including gastrointestinal and gastric cancer. A phar...
Invention Sorting with counter selection using sequence similar peptides. The present invention relates to...
Invention Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (h...
Invention Peptides displayed by mhc for use in immunotherapy against different types of cancer. Provided is...
Invention Method of determining mhc-presented peptides. A method, implemented by at least one processor, fo...
Invention Antigen binding proteins against mageb2. The present invention relates to antigen binding protei...
Invention Antigen binding proteins against mageb2. The present invention relates to antigen binding protein...
Invention Novel t cell receptors targeting melanoma-associated antigen (mage) b2 and immune therapy using t...
Invention A method of identifying mhc-binding proteins and interacting peptides in a sample. The present in...
Invention Peptides for use in immunotherapy against cancers. The present invention relates to peptides, pr...
Invention Novel peptides & combination of peptides as targets or active ingredients for use in immunotherap...
Invention Novel peptides and combination of peptides for use in immunotherapy against various tumors. A me...
Invention Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers...
Invention Novel t cell receptors and immune therapy using the same. The present invention pertains to anti...
Invention Method for the absolute quantification of naturally processed hla-restricted cancer peptides. Th...
Invention Peptides displayed by hla for use in immunotherapy against different types of cancers. The inven...
Invention Peptides displayed by hla for use in immunotherapy against different types of cancers. The invent...
Invention Peptides displayed by hla for use immunotherapy against different types of cancers. The invention...
Invention Transfected t-cells and t-cell receptors for use in immunotherapy against cancers. Disclosed are...
Invention Novel engineered t cell receptors and immune therapy using the same. The present invention perta...
Invention Amidated peptides and their deamidated counterparts displayed by non-hla-a*02 for use in immunoth...
2022 Invention Stabilized mhc molecules. The present invention relates to a composition comprising a major hist...
Invention Selection of immune cells using peptide mhc complexes generated by conditional ligand exchange. ...
2021 G/S Bioinformatics software; graphical user interface software; artificial intelligence and machine ...
G/S Bioinformatics software; graphical user interface software; artificial intelligence and machine l...
2020 G/S Medical and veterinary preparations and articles, namely medicines for cancer treatment and natur...
G/S Pharmaceutical products, namely biological and chemical preparations for the medical treatment of...
G/S Financial planning services; financial management; financial information; financial investment br...
G/S Financial planning services; financial appraisal services; financial management; financial inform...
G/S Medical and veterinary preparations and articles, namely, medicines and natural remedies, and dia...
G/S Medical and veterinary preparations and articles, Namely medicines and natural remedies, and diag...
G/S Medical and veterinary preparations, namely, oncological, anti-viral, anti-bacterial and autoimmu...
G/S Medical and veterinary preparations and articles, namely medicines and natural remedies, and dia...
2019 G/S Medical and pharmaceutical products, namely, pharmaceutical preparations for the treatment of onc...
G/S Medical and pharmaceutical products; diagnostic reagents for medical purposes; peptides, protein...
G/S Medical and veterinary pharmaceutical preparations and compositions, namely, medicines and natura...
G/S Pharmaceutical preparations for medical purposes, namely, pharmaceutical preparations for the dia...
G/S Medical and pharmaceutical products, namely, oncological, anti-viral, anti-bacterial and autoimmu...
G/S Medical and pharmaceutical products; diagnostic reagents for medical purposes; peptides, proteins...
2018 G/S Conducting research and clinical trials relating to the use and the engineering of t-cells and ca...
G/S Research and development in the pharmaceutical and biotechnology fields; development of pharmaceu...
G/S Pharmaceuticals; pharmaceutical drugs; pharmaceutical compositions; pharmaceutical preparations....
G/S Medical and veterinary preparations using a combination of medicines and natural remedies, and di...